FR2231365A1 - - Google Patents

Info

Publication number
FR2231365A1
FR2231365A1 FR7418230A FR7418230A FR2231365A1 FR 2231365 A1 FR2231365 A1 FR 2231365A1 FR 7418230 A FR7418230 A FR 7418230A FR 7418230 A FR7418230 A FR 7418230A FR 2231365 A1 FR2231365 A1 FR 2231365A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7418230A
Other languages
French (fr)
Other versions
FR2231365B1 (nl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2231365A1 publication Critical patent/FR2231365A1/fr
Application granted granted Critical
Publication of FR2231365B1 publication Critical patent/FR2231365B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7418230A 1973-05-29 1974-05-27 Expired FR2231365B1 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36444373A 1973-05-29 1973-05-29

Publications (2)

Publication Number Publication Date
FR2231365A1 true FR2231365A1 (nl) 1974-12-27
FR2231365B1 FR2231365B1 (nl) 1977-11-04

Family

ID=23434551

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7418230A Expired FR2231365B1 (nl) 1973-05-29 1974-05-27

Country Status (4)

Country Link
JP (1) JPS5031022A (nl)
DE (1) DE2425764A1 (nl)
FR (1) FR2231365B1 (nl)
GB (1) GB1422768A (nl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
EP0577504A1 (en) * 1992-06-29 1994-01-05 Upsher-Smith Laboratories, Inc. Niacin-containing sustained-release tablets and kits

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS5974374U (ja) * 1982-11-11 1984-05-19 セイコーインスツルメンツ株式会社 携帯時計の文字板保持構造
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
CA2947308A1 (en) * 2013-05-09 2014-11-13 Zeenar Enterprises Pty Ltd Niacin formulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137156A (en) * 1965-10-12 1968-12-18 Leo Pharm Prod Ltd Improvements in or relating to the manufacture of sustained release pharmaceutical tablets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137156A (en) * 1965-10-12 1968-12-18 Leo Pharm Prod Ltd Improvements in or relating to the manufacture of sustained release pharmaceutical tablets

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
EP0577504A1 (en) * 1992-06-29 1994-01-05 Upsher-Smith Laboratories, Inc. Niacin-containing sustained-release tablets and kits
EP1310253A1 (en) * 1992-06-29 2003-05-14 Kos Pharmaceuticals, Inc. Niacin-containing sustained-release tablets and kits

Also Published As

Publication number Publication date
FR2231365B1 (nl) 1977-11-04
GB1422768A (en) 1976-01-28
JPS5031022A (nl) 1975-03-27
DE2425764A1 (de) 1975-01-02

Similar Documents

Publication Publication Date Title
AU465372B2 (nl)
AR201235Q (nl)
AR201231Q (nl)
AU474593B2 (nl)
AU474511B2 (nl)
AU474838B2 (nl)
AU471343B2 (nl)
AU465453B2 (nl)
AU465434B2 (nl)
AU450229B2 (nl)
JPS5031022A (nl)
AR201229Q (nl)
AU466283B2 (nl)
AU472848B2 (nl)
AR199451A1 (nl)
JPS5025114U (nl)
AU461342B2 (nl)
AU447540B2 (nl)
AR201432A1 (nl)
AR197627A1 (nl)
AU471461B2 (nl)
AR210729A1 (nl)
AR196382A1 (nl)
AU1891376A (nl)
AR196212Q (nl)

Legal Events

Date Code Title Description
ST Notification of lapse